Data from Involvement of Mitochondrial DNA Sequence Variations and Respiratory Activity in Late Complications following Radiotherapy Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.c.6517662.v1
Purpose: Mitochondria and ionizing radiation overlap in a number of features; for instance, both generate harmful reactive oxygen species, and that radiation can induce cell death through the intermediary of mitochondria. Because a number of genetic variations in nuclear genes are frequently associated with response to cancer treatment, the aim of this case-control study was to test the hypothesis that mitochondrial DNA (mtDNA) genetic variations can contribute to patient-to-patient variability in normal tissue response to radiotherapy.Experimental Design: Thirty-two nasopharyngeal carcinomas patients treated with definitive radiotherapy were included. The grade (G) of s.c. and deep tissue fibrosis was scored according to the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer grading system. Coding and RNA mtDNA (between 611 and 15,978 bp) were sequenced, and genetic variations were scored. Mitochondrial respiratory activity was measured by resazurin reduction assay.Results: Data showed a significantly (P = 0.003) higher number of nonsynonymous genetic variations in the radiosensitive (G2-G3; 16 patients) as compared with the control (G0-G1; 16 patients) groups. The nonsynonymous A10398G variation in the ND3 gene was significantly associated with fibrotic reaction (P = 0.01). The radiosensitive patients had a 7-fold (95% confidence interval, 1.16-51.65) higher risk of developing moderate to severe fibrosis (G2-G3) following radiotherapy. This was significantly correlated with lower mitochondrial respiratory activity (P = 0.001).Conclusion: Mitochondria contribute to radiation sensitivity, and genetic variations can be associated with late reactions to radiotherapy. Predictive markers of radiosensitivity should take into account mtDNA genetic variations in addition to variations in nuclear genes. (Clin Cancer Res 2009;15(23):7352–60)
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.c.6517662.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361949134
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361949134Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.c.6517662.v1Digital Object Identifier
- Title
-
Data from Involvement of Mitochondrial DNA Sequence Variations and Respiratory Activity in Late Complications following RadiotherapyWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Ghazi Alsbeih, Najla Al-Harbi, Medhat El-Sebaie, Nasser Al-Rajhi, Khaled Al-Hadyan, Khaled K. Abu‐AmeroList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.c.6517662.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.c.6517662.v1Direct OA link when available
- Concepts
-
Mitochondrial DNA, Radiation therapy, Biology, Nonsynonymous substitution, Molecular biology, Medicine, Internal medicine, Genetics, Gene, GenomeTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361949134 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.c.6517662.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.c.6517662.v1 |
| ids.openalex | https://openalex.org/W4361949134 |
| fwci | 0.0 |
| type | preprint |
| title | Data from Involvement of Mitochondrial DNA Sequence Variations and Respiratory Activity in Late Complications following Radiotherapy |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10202 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9858999848365784 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Lung Cancer Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10301 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9832000136375427 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Mitochondrial Function and Pathology |
| topics[2].id | https://openalex.org/T11482 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.972599983215332 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | RNA modifications and cancer |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C24586158 |
| concepts[0].level | 3 |
| concepts[0].score | 0.6788623332977295 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q27075 |
| concepts[0].display_name | Mitochondrial DNA |
| concepts[1].id | https://openalex.org/C509974204 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5606590509414673 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q180507 |
| concepts[1].display_name | Radiation therapy |
| concepts[2].id | https://openalex.org/C86803240 |
| concepts[2].level | 0 |
| concepts[2].score | 0.45754262804985046 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[2].display_name | Biology |
| concepts[3].id | https://openalex.org/C149904235 |
| concepts[3].level | 4 |
| concepts[3].score | 0.4341799020767212 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7049620 |
| concepts[3].display_name | Nonsynonymous substitution |
| concepts[4].id | https://openalex.org/C153911025 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3441299796104431 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[4].display_name | Molecular biology |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.32111191749572754 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3144574761390686 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C54355233 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3034070134162903 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[7].display_name | Genetics |
| concepts[8].id | https://openalex.org/C104317684 |
| concepts[8].level | 2 |
| concepts[8].score | 0.2835193872451782 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[8].display_name | Gene |
| concepts[9].id | https://openalex.org/C141231307 |
| concepts[9].level | 3 |
| concepts[9].score | 0.17094802856445312 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7020 |
| concepts[9].display_name | Genome |
| keywords[0].id | https://openalex.org/keywords/mitochondrial-dna |
| keywords[0].score | 0.6788623332977295 |
| keywords[0].display_name | Mitochondrial DNA |
| keywords[1].id | https://openalex.org/keywords/radiation-therapy |
| keywords[1].score | 0.5606590509414673 |
| keywords[1].display_name | Radiation therapy |
| keywords[2].id | https://openalex.org/keywords/biology |
| keywords[2].score | 0.45754262804985046 |
| keywords[2].display_name | Biology |
| keywords[3].id | https://openalex.org/keywords/nonsynonymous-substitution |
| keywords[3].score | 0.4341799020767212 |
| keywords[3].display_name | Nonsynonymous substitution |
| keywords[4].id | https://openalex.org/keywords/molecular-biology |
| keywords[4].score | 0.3441299796104431 |
| keywords[4].display_name | Molecular biology |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.32111191749572754 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.3144574761390686 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/genetics |
| keywords[7].score | 0.3034070134162903 |
| keywords[7].display_name | Genetics |
| keywords[8].id | https://openalex.org/keywords/gene |
| keywords[8].score | 0.2835193872451782 |
| keywords[8].display_name | Gene |
| keywords[9].id | https://openalex.org/keywords/genome |
| keywords[9].score | 0.17094802856445312 |
| keywords[9].display_name | Genome |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.c.6517662.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.c.6517662.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5007141199 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2128-6293 |
| authorships[0].author.display_name | Ghazi Alsbeih |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ghazi A. Alsbeih |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5059034793 |
| authorships[1].author.orcid | https://orcid.org/0009-0004-8009-9502 |
| authorships[1].author.display_name | Najla Al-Harbi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Najla M. Al-Harbi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5108833516 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Medhat El-Sebaie |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Medhat M. El-Sebaie |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5112905029 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Nasser Al-Rajhi |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nasser M. Al-Rajhi |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5061731765 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1674-8016 |
| authorships[4].author.display_name | Khaled Al-Hadyan |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Khaled S. Al-Hadyan |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5026152456 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3067-8966 |
| authorships[5].author.display_name | Khaled K. Abu‐Amero |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Khaled K. Abu-Amero |
| authorships[5].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.c.6517662.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Data from Involvement of Mitochondrial DNA Sequence Variations and Respiratory Activity in Late Complications following Radiotherapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10202 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9858999848365784 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Lung Cancer Diagnosis and Treatment |
| related_works | https://openalex.org/W2151009083, https://openalex.org/W1988328886, https://openalex.org/W2113286403, https://openalex.org/W3063015752, https://openalex.org/W1899066580, https://openalex.org/W1993873746, https://openalex.org/W2155896987, https://openalex.org/W4251822328, https://openalex.org/W2587512014, https://openalex.org/W2028961943 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.c.6517662.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.c.6517662.v1 |
| primary_location.id | doi:10.1158/1078-0432.c.6517662.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.c.6517662.v1 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.= | 144, 182, 215 |
| abstract_inverted_index.a | 7, 32, 141, 188 |
| abstract_inverted_index.16 | 156, 164 |
| abstract_inverted_index.as | 158 |
| abstract_inverted_index.be | 226 |
| abstract_inverted_index.by | 135 |
| abstract_inverted_index.in | 6, 37, 70, 152, 171, 244, 248 |
| abstract_inverted_index.of | 9, 29, 34, 50, 90, 110, 148, 196, 235 |
| abstract_inverted_index.to | 45, 55, 67, 74, 99, 199, 219, 231, 246 |
| abstract_inverted_index.(G) | 89 |
| abstract_inverted_index.611 | 119 |
| abstract_inverted_index.DNA | 61 |
| abstract_inverted_index.RNA | 116 |
| abstract_inverted_index.Res | 253 |
| abstract_inverted_index.The | 87, 167, 184 |
| abstract_inverted_index.aim | 49 |
| abstract_inverted_index.and | 2, 19, 92, 108, 115, 120, 125, 222 |
| abstract_inverted_index.are | 40 |
| abstract_inverted_index.bp) | 122 |
| abstract_inverted_index.can | 22, 65, 225 |
| abstract_inverted_index.for | 11, 106 |
| abstract_inverted_index.had | 187 |
| abstract_inverted_index.the | 27, 48, 57, 100, 153, 161, 172 |
| abstract_inverted_index.was | 54, 96, 133, 175, 206 |
| abstract_inverted_index.(95% | 190 |
| abstract_inverted_index.Data | 139 |
| abstract_inverted_index.This | 205 |
| abstract_inverted_index.both | 13 |
| abstract_inverted_index.cell | 24 |
| abstract_inverted_index.deep | 93 |
| abstract_inverted_index.gene | 174 |
| abstract_inverted_index.into | 239 |
| abstract_inverted_index.late | 229 |
| abstract_inverted_index.risk | 195 |
| abstract_inverted_index.s.c. | 91 |
| abstract_inverted_index.take | 238 |
| abstract_inverted_index.test | 56 |
| abstract_inverted_index.that | 20, 59 |
| abstract_inverted_index.this | 51 |
| abstract_inverted_index.were | 85, 123, 128 |
| abstract_inverted_index.with | 43, 82, 160, 178, 209, 228 |
| abstract_inverted_index.(Clin | 251 |
| abstract_inverted_index.death | 25 |
| abstract_inverted_index.genes | 39 |
| abstract_inverted_index.grade | 88 |
| abstract_inverted_index.lower | 210 |
| abstract_inverted_index.mtDNA | 117, 241 |
| abstract_inverted_index.study | 53 |
| abstract_inverted_index.0.003) | 145 |
| abstract_inverted_index.0.01). | 183 |
| abstract_inverted_index.15,978 | 121 |
| abstract_inverted_index.7-fold | 189 |
| abstract_inverted_index.Cancer | 111, 252 |
| abstract_inverted_index.Coding | 114 |
| abstract_inverted_index.cancer | 46 |
| abstract_inverted_index.genes. | 250 |
| abstract_inverted_index.higher | 146, 194 |
| abstract_inverted_index.induce | 23 |
| abstract_inverted_index.normal | 71 |
| abstract_inverted_index.number | 8, 33, 147 |
| abstract_inverted_index.oxygen | 17 |
| abstract_inverted_index.scored | 97 |
| abstract_inverted_index.severe | 200 |
| abstract_inverted_index.should | 237 |
| abstract_inverted_index.showed | 140 |
| abstract_inverted_index.tissue | 72, 94 |
| abstract_inverted_index.(mtDNA) | 62 |
| abstract_inverted_index.Because | 31 |
| abstract_inverted_index.Therapy | 102 |
| abstract_inverted_index.account | 240 |
| abstract_inverted_index.control | 162 |
| abstract_inverted_index.genetic | 35, 63, 126, 150, 223, 242 |
| abstract_inverted_index.grading | 112 |
| abstract_inverted_index.groups. | 166 |
| abstract_inverted_index.harmful | 15 |
| abstract_inverted_index.markers | 234 |
| abstract_inverted_index.nuclear | 38, 249 |
| abstract_inverted_index.overlap | 5 |
| abstract_inverted_index.scored. | 129 |
| abstract_inverted_index.system. | 113 |
| abstract_inverted_index.through | 26 |
| abstract_inverted_index.treated | 81 |
| abstract_inverted_index.(between | 118 |
| abstract_inverted_index.Oncology | 103 |
| abstract_inverted_index.Research | 107 |
| abstract_inverted_index.activity | 132, 213 |
| abstract_inverted_index.addition | 245 |
| abstract_inverted_index.compared | 159 |
| abstract_inverted_index.fibrosis | 95, 201 |
| abstract_inverted_index.fibrotic | 179 |
| abstract_inverted_index.generate | 14 |
| abstract_inverted_index.ionizing | 3 |
| abstract_inverted_index.measured | 134 |
| abstract_inverted_index.moderate | 198 |
| abstract_inverted_index.patients | 80, 186 |
| abstract_inverted_index.reaction | 180 |
| abstract_inverted_index.reactive | 16 |
| abstract_inverted_index.response | 44, 73 |
| abstract_inverted_index.species, | 18 |
| abstract_inverted_index.Radiation | 101 |
| abstract_inverted_index.Treatment | 109 |
| abstract_inverted_index.according | 98 |
| abstract_inverted_index.features; | 10 |
| abstract_inverted_index.following | 203 |
| abstract_inverted_index.included. | 86 |
| abstract_inverted_index.instance, | 12 |
| abstract_inverted_index.interval, | 192 |
| abstract_inverted_index.patients) | 157, 165 |
| abstract_inverted_index.radiation | 4, 21, 220 |
| abstract_inverted_index.reactions | 230 |
| abstract_inverted_index.reduction | 137 |
| abstract_inverted_index.resazurin | 136 |
| abstract_inverted_index.variation | 170 |
| abstract_inverted_index.Predictive | 233 |
| abstract_inverted_index.Thirty-two | 77 |
| abstract_inverted_index.associated | 42, 177, 227 |
| abstract_inverted_index.carcinomas | 79 |
| abstract_inverted_index.confidence | 191 |
| abstract_inverted_index.contribute | 66, 218 |
| abstract_inverted_index.correlated | 208 |
| abstract_inverted_index.definitive | 83 |
| abstract_inverted_index.developing | 197 |
| abstract_inverted_index.frequently | 41 |
| abstract_inverted_index.hypothesis | 58 |
| abstract_inverted_index.sequenced, | 124 |
| abstract_inverted_index.treatment, | 47 |
| abstract_inverted_index.variations | 36, 64, 127, 151, 224, 243, 247 |
| abstract_inverted_index.1.16-51.65) | 193 |
| abstract_inverted_index.respiratory | 131, 212 |
| abstract_inverted_index.variability | 69 |
| abstract_inverted_index.Mitochondria | 1, 217 |
| abstract_inverted_index.Organization | 105 |
| abstract_inverted_index.case-control | 52 |
| abstract_inverted_index.intermediary | 28 |
| abstract_inverted_index.radiotherapy | 84 |
| abstract_inverted_index.sensitivity, | 221 |
| abstract_inverted_index.Mitochondrial | 130 |
| abstract_inverted_index.mitochondria. | 30 |
| abstract_inverted_index.mitochondrial | 60, 211 |
| abstract_inverted_index.nonsynonymous | 149, 168 |
| abstract_inverted_index.radiotherapy. | 204, 232 |
| abstract_inverted_index.significantly | 142, 176, 207 |
| abstract_inverted_index.Group/European | 104 |
| abstract_inverted_index.nasopharyngeal | 78 |
| abstract_inverted_index.radiosensitive | 154, 185 |
| abstract_inverted_index.radiosensitivity | 236 |
| abstract_inverted_index.Design:</b> | 76 |
| abstract_inverted_index.patient-to-patient | 68 |
| abstract_inverted_index.(<i>P</i> | 143, 181, 214 |
| abstract_inverted_index.<i>ND3</i> | 173 |
| abstract_inverted_index.2009;15(23):7352–60)</p></div> | 254 |
| abstract_inverted_index.<i>A</i>10398<i>G</i> | 169 |
| abstract_inverted_index.assay.</p><p><b>Results:</b> | 138 |
| abstract_inverted_index.(G<sub>0</sub>-G<sub>1</sub>; | 163 |
| abstract_inverted_index.(G<sub>2</sub>-G<sub>3</sub>) | 202 |
| abstract_inverted_index.(G<sub>2</sub>-G<sub>3</sub>; | 155 |
| abstract_inverted_index.radiotherapy.</p><p><b>Experimental | 75 |
| abstract_inverted_index.<div>Abstract<p><b>Purpose:</b> | 0 |
| abstract_inverted_index.0.001).</p><p><b>Conclusion:</b> | 216 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.13220876 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |